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Monastrol [1] is a small molecule
that inhibits a mitotic kinesin
called Eg5. In cells, monastrol
dramatically arrests mitosis with a
defect in the engagement and
relative sliding of the two half-
spindles [1,2]. We show here that
monastrol stabilises a remarkable
low-friction attached mode of Eg5
that binds stably to microtubules,
yet can be readily slid along them.
We will suggest that this mode is
part of the normal Eg5 kinetic
cycle (‘on-pathway’), with
significant consequences for the
in vivo role of Eg5 and for the
interpretation of experiments
involving monastrol.
Monastrol inhibits Eg5 by an
allosteric mechanism, binding to
an Eg5–ADP complex and
specifically inhibiting ADP release
[3,4]. A recent crystal structure of
the Eg5–ADP–monastrol ternary
complex reveals that monastrol
binds just beneath the active site,
in a self-created pocket
comprising elements of the α2
and α3 helices [5]. Monastrol does
not bind to other kinesins. The
crystal structure of the
monastrol–ADP–Eg5 complex is
very similar to that of a previously
determined structure of Kif1a [6]
that was interpreted as a strong
binding complex. Accordingly, it
was suggested [5] that monastrol
stabilises a strong binding state of
Eg5. In this case, ‘strong binding
state’ refers to a stable,
stereospecifically attached state
that can bear force, as opposed to
a weak binding state that
detaches rapidly and cannot bear
force. Consistent with the idea
that monastrol stabilises a strong
binding state, monastrol inhibits
Eg5-driven motility in surface
sliding assays, but does not cause
the microtubules to dissociate
from the Eg5 surface [1]. On the
other hand, kinetic data indicate
that monastrol stabilises an ADP
state of Eg5, and Eg5–ADP is
reported to be a weak binding
state with a low affinity for
microtubules [7].
To find out whether the ternary
Eg5–monastrol–ADP complex is
binding weakly or strongly to
microtubules, we ran ‘tug-o’-war’
motility assays in which
microtubules move on mixed
surfaces of kinesin (rat brain
kinesin 1, kif5b) and Eg5 (Xenopus
Eg 5.2). Monastrol inhibits only the
Eg5 component on these mixed
surfaces, allowing us to ask
whether the rat kinesin can
overcome the frictional resistance
due to monastrol-inhibited Eg5.
Figure 1 shows that on surfaces of
Eg5 alone, microtubules slid at
0.07 µm s-1, while on rat kinesin
alone, microtubules slid at 0.56
µm s-1. On mixed surfaces of Eg5
and kif5b, microtubules moved at
0.24 µm s-1, indicating that the
more slowly cycling Eg5 motor
works as a brake on the rat
kinesin-driven motility. When we
added monastrol, microtubules on
the Eg5 surface arrested, while the
velocity of those on the mixed
surface approximately doubled to
0.46 µm s-1. We thus find that
monastrol decreases the drag
force exerted by the microtubule-
bound Eg5 heads, implying that
the ternary Eg5–ADP–monastrol
complex indeed tends to remain
attached to microtubules, but that
the attachment exerts negligible
molecular friction.
Our data thus indicate that
monastrol stabilises an Eg5–ADP
state or states that bind
microtubules but can be slid along
them with little frictional
resistance. Is this monastrol state
on-pathway for the Eg5 ATPase?
We reasoned that if monastrol is
stabilising and enriching a weakly
binding Eg5–ADP state that is on-
pathway, then it should be
possible to produce monastrol-
like inhibition of Eg5 just by
adding ADP. For rat kinesin, the
affinity of the motor for ADP is
similar to that for ATP, so that
adding equimolar ADP and ATP
reduces velocity by about 50% [8].
For Eg5-driven sliding, the
inhibitory effects of added ADP
are dramatically enhanced by
adding monastrol (Figure 1B). This
synergy is consistent with an
allosteric mechanism in which
monastrol increases the affinity of
Eg5 for ADP, thereby stabilising a
pre-existing, on-pathway,
Eg5–ADP conformation. We
supported this interpretation using
proteolytic fingerprinting to
demonstrate a monastrol-
dependent increase in the ADP
binding affinity of Eg5
(Supplemental Data).
Supposing that the low-friction
Eg5–ADP “monastrol state” is
indeed on-pathway for the normal
kinetic cycle of Eg5, how would it
fit into the kinetic scheme, and
what might be its function? Figure
1C shows a possible scheme, in
which the “monastrol state” of Eg5
is a composite of on-pathway
attached and detached trapped
ADP states in rapid equilibrium.
Wild-type Eg5 self-assembles into
antiparallel tetramers [9]. The
proposed on-pathway low-friction
state of Eg5 would have
interesting consequences for the
function of tetramers. Individual
two-headed Eg5 molecules are
non-processive [10], but an array
of connected tetramers would be
processive, because attachment
would be maintained by low-
friction Eg5–ADP heads. In this
model, a single power stroke by an
individual head within an array can
move the whole array along the
microtubule. Potentially analogous
long-lived low friction states have
been reported for the kif1a kinesin
[11] and for dynein–ADP–vanadate
[12]. By allowing a single power
stroke to slide an oligomeric team
of connected heads, processivity
of the team can be maintained
even where individual strokes are
appreciably smaller than the 8 nm
axial distance between successive
binding sites on the microtubule.
In vivo, Eg5 tetramers are
believed to crosslink pairs of
antiparallel spindle microtubules.
Kapoor, Mitchison and colleagues
[2] reported that under monastrol
treatment Eg5 in the spindle
remains fixed while the microtubule
lattice treadmills (fluxes) beneath
the motor, and suggested that the
Eg5 molecules might be anchored
to a separate spindle matrix. Our
data suggest an alternative
possibility, that the bulk population
of Eg5 might be attached in a low
friction state to antiparallel spindle
microtubules, allowing treadmilling
to continue without shifting the
position of attached Eg5
molecules. Monastrol treatment of
pre-assembled spindles collapses
the spindles. Our data suggest that
this is likely to be due to an active
disengagement of antiparallel
spindle microtubules, perhaps
produced by minus-end-directed
spindle motors that in ordinary
circumstances oppose and
balance the plus-end-directed
sliding action of Eg5.
Supplemental data
Supplemental data containing
experimental procedures are
available at http://www.current-
biology.com/cgi/content/full/14/1
1/R411/DC1/
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Figure 1. Effects of monastrol in tug-o’-war sliding assays.
Microtubule sliding assays were run in ~20 µl flow cells and motility visualised using
video-enhanced DIC microscopy. Monastrol inhibition was produced by flowing in
motility buffer (MB) containing 400 µM monastrol. The inhibition was titratable (Supple-
mental Data) and reversible on wash-out. (A) Effects of monastrol on kinesin alone, Eg5
alone, or a 1:1 mix, as indicated. (B) ATP concentration-dependence of motility in MB
or MB plus 400 µM ADP or MB plus 400 µM ADP plus 50 µM monastrol. The fits are
hyperbolic binding curves, with maxima 0.07, 0.07 and 0.05 µm s-1, respectively, and
apparent affinities for ATP 70 µM, 170 µM and 320 µM, respectively. (C) Kinetic scheme
(M = microtubules, K = kinesin). Microtubule binding and release occurs via a compos-
ite state composed of free and bound KTRAPPED.ADP heads in rapid equilibrium. Monas-
trol is proposed to enrich this weakly binding composite state.
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